Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 27, 2010
- Accepted after revision June 27, 2010
- Published online February 11, 2011.
Article Versions
- Latest version (November 11, 2010 - 06:48).
- Latest version (November 24, 2010 - 06:44).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
- R. Jaina,b,
- J. Gutierrezd,
- J. Naranga,
- L. Scarpaceb,
- L.R. Schultzc,
- N. Lemkeb,
- S.C. Patela,
- T. Mikkelsenb and
- J.P. Rockb
- aFrom the Division of Neuroradiology, Department of Radiology (R.J., J.N., S.C.P.)
- bDepartment of Neurosurgery (R.J., J.P.R., L.S., N.L., T.M.)
- cDepartment of Biostatistics and Research Epidemiology (L.R.S.)
- dDepartment of Pathology (J.G.), Henry Ford Health System, Detroit, Michigan.
- Please address correspondence to: Rajan Jain, MD, Division of Neuroradiology, Department of Radiology and Neurosurgery, Henry Ford Health System, 2799 West Grand Blvd, Detroit MI 48202; e-mail: rajanj{at}rad.hfh.edu
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis
- Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging
- Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas
- Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging
- T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
- Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade
- Histogram Analysis of Intravoxel Incoherent Motion for Differentiating Recurrent Tumor from Treatment Effect in Patients with Glioblastoma: Initial Clinical Experience
- Intratumoral Modeling of Gefitinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma
- Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study
- Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study
- Perfusion CT Imaging of Brain Tumors: An Overview
- Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?